ALPS Advisors’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $298K | Buy |
+64,508
| New | +$244K | ﹤0.01% | 1084 |
|
|
2025
Q2 | – | Sell |
-48,646
| Closed | -$61.8K | – | 1046 |
|
|
2025
Q1 | $61.8K | Sell |
48,646
-2,104
| -4% | -$5.5K | ﹤0.01% | 985 |
|
|
2024
Q4 | $165K | Buy |
+50,750
| New | +$183K | ﹤0.01% | 977 |
|
|
2024
Q2 | – | Sell |
-43,752
| Closed | -$644K | – | 986 |
|
|
2024
Q1 | $644K | Buy |
43,752
+2,078
| +5% | +$31.4K | ﹤0.01% | 562 |
|
|
2023
Q4 | $401K | Sell |
41,674
-4,020
| -9% | -$27.8K | ﹤0.01% | 669 |
|
|
2023
Q3 | $213K | Buy |
45,694
+241
| +0.5% | +$1.2K | ﹤0.01% | 956 |
|
|
2023
Q2 | $243K | Buy |
+45,453
| New | +$280K | ﹤0.01% | 953 |
|
|
2022
Q2 | – | Sell |
-63,024
| Closed | -$555K | – | 1075 |
|
|
2022
Q1 | $555K | Sell |
63,024
-7,865
| -11% | -$86.8K | 0.01% | 417 |
|
|
2021
Q4 | $1.14M | Sell |
70,889
-4,008
| -5% | -$75.4K | 0.01% | 344 |
|
|
2021
Q3 | $1.57M | Sell |
74,897
-4,180
| -5% | -$101K | 0.02% | 345 |
|
|
2021
Q2 | $2.12M | Buy |
+79,077
| New | +$2.32M | 0.02% | 318 |
|
|
2020
Q2 | – | Sell |
-88,930
| Closed | -$518K | – | 813 |
|
|
2020
Q1 | $518K | Sell |
88,930
-10,372
| -10% | -$94.2K | 0.01% | 431 |
|
|
2019
Q4 | $1.08M | Buy |
99,302
+1,815
| +2% | +$18K | 0.01% | 332 |
|
|
2019
Q3 | $1.24M | Sell |
97,487
-4,656
| -5% | -$67.1K | 0.01% | 270 |
|
|
2019
Q2 | $1.73M | Sell |
102,143
-15,179
| -13% | -$261K | 0.01% | 245 |
|
|
2019
Q1 | $2.11M | Buy |
117,322
+19,659
| +20% | +$340K | 0.01% | 221 |
|
|
2018
Q4 | $1.24M | Buy |
97,663
+22,921
| +31% | +$384K | 0.01% | 260 |
|
|
2018
Q3 | $1.6M | Buy |
74,742
+13,500
| +22% | +$288K | 0.01% | 280 |
|
|
2018
Q2 | $1.26M | Buy |
+61,242
| New | +$1.38M | 0.01% | 292 |
|
|
2017
Q4 | – | Sell |
-36,239
| Closed | -$670K | – | 865 |
|
|
2017
Q3 | $670K | Buy |
36,239
+4,635
| +15% | +$80.3K | ﹤0.01% | 317 |
|
|
2017
Q2 | $553K | Buy |
31,604
+1,635
| +5% | +$31.2K | ﹤0.01% | 409 |
|
|
2017
Q1 | $557K | Sell |
29,969
-3,508
| -10% | -$67.7K | ﹤0.01% | 317 |
|
|
2016
Q4 | $684K | Sell |
33,477
-10,802
| -24% | -$272K | 0.01% | 246 |
|
|
2016
Q3 | $1.32M | Sell |
44,279
-4,251
| -9% | -$126K | 0.01% | 208 |
|
|
2016
Q2 | $1.31M | Buy |
48,530
+9,942
| +26% | +$224K | 0.01% | 199 |
|
|
2016
Q1 | $724K | Sell |
38,588
-6,613
| -15% | -$126K | 0.01% | 198 |
|
|
2015
Q4 | $1.4M | Sell |
45,201
-8,325
| -16% | -$253K | 0.01% | 197 |
|
|
2015
Q3 | $1.15M | Buy |
53,526
+23,721
| +80% | +$744K | 0.01% | 207 |
|
|
2015
Q2 | $1.13M | Buy |
29,805
+15,084
| +102% | +$496K | 0.01% | 206 |
|
|
2015
Q1 | $462K | Buy |
+14,721
| New | +$499K | ﹤0.01% | 609 |
|
Other funds holding MGNX
AC
WA
RCM
ALPS Advisors's MGNX Position: Q2 2026 in Review
ALPS Advisors opened a new position in MacroGenics (MGNX) in Q2 2026: 64,508 shares worth $298K. The stake represents ﹤0.01% of the portfolio and ranks #1084 among its holdings. This is a return to the name: ALPS Advisors previously reported a position in MGNX as recently as Q1 2025.
ALPS Advisors first reported a position in MGNX in Q1 2015 and has held it in 30 quarters since. The position peaked at $2.12M in Q2 2021. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.
- ALPS Advisors held 64,508 shares of MacroGenics worth $298K as of Q2 2026.
- MacroGenics was a new ALPS Advisors position in Q2 2026.
- MacroGenics made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #1084 holding.
- ALPS Advisors first reported a position in MacroGenics in Q1 2015 and has held it in 30 quarters since.
- ALPS Advisors's MacroGenics position peaked at $2.12M in Q2 2021.
- 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.
Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.